-
Mashup Score: 1
Shionogi’s therapy, ensitrelvir, was found to reduce and prevent these issues.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 1 year(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
Observations from ID and Beyond: Three Effective #COVID19Treatments Not in Treatment Guidelines — At Least Not Yet @PaulSaxMD @BrighamWomens @harvardmed https://t.co/IfDfK6DV0s @JWatch [subscription] #Ensitrelvir #Metformin #PegylatedInterferonLambda https://t.co/uxOtXW7LbB
-
-
Mashup Score: 2Three effective treatments for COVID-19 not (yet) in guidelines - 1 year(s) ago
Paul Sax: [00:00:02] Hello, this is Paul Sax. I’m Editor-in-Chief of Clinical Infectious Diseases and welcome to the Let’s Talk ID podcast. Today, I’m delighted to be joined by Dr. David Boulware, professor of medicine at University of Minnesota, where he is in the Division of Infectious Diseases and International Medicine. He joined me around three years ago toward the start of the pandemic…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
"The data on symptoms of long COVID were among the most convincing data we've seen.” @PaulSaxMD & @boulware_dr discuss recent findings on #ensitrelvir, a COVID-19 treatment available in Japan. Listen: https://t.co/9McA5GBwzN *A transcript is available https://t.co/UtliqCTwJc
-
-
Mashup Score: 3Three effective treatments for COVID-19 not (yet) in guidelines - 1 year(s) ago
Paul Sax: [00:00:02] Hello, this is Paul Sax. I’m Editor-in-Chief of Clinical Infectious Diseases and welcome to the Let’s Talk ID podcast. Today, I’m delighted to be joined by Dr. David Boulware, professor of medicine at University of Minnesota, where he is in the Division of Infectious Diseases and International Medicine. He joined me around three years ago toward the start of the pandemic…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
NEW #LetsTalkID episode! @PaulSaxMD & @boulware_dr discuss promising studies of #interferonlambda, #metformin and #ensitrelvir for COVID-19 & why none of them is currently in treatment guidelines. Available wherever you listen to podcasts. *transcript: https://t.co/9McA5GC4pl https://t.co/PTZWys5RI1
-
-
Mashup Score: 2Shionogi says COVID pill trial shows reduction in symptoms - 2 year(s) ago
Japan’s Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.
Source: ReutersCategories: Expert Picks, Latest HeadlinesTweet-
Japan's Shionogi & Co oral treatment for #COVID19 #ensitrelvir reduced symptoms in a Phase III trial of predominantly vaccinated patients with mild to moderate cases of COVID-19 https://t.co/wqZR0QtWo5
-
The @SHIONOGI_JP therapy #ensitrelvir was found to reduce and prevent these issues. https://t.co/0fGFHfW2rH